Dianthus Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:DNTH Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
03 Dec 24	BuyUS$6,376,788	Avidity Partners Management, L.P.	Company	250,000	US$25.69
25 Nov 24	SellUS$5,403,509	Avidity Partners Management, L.P.	Company	238,498	US$25.68
22 Jan 24	BuyUS$18,000,000	Avidity Partners Management, L.P.	Company	1,500,000	US$12.00
22 Jan 24	BuyUS$10,012,008	Fairmount Funds Management LLC	Company	834,334	US$12.00
22 Jan 24	BuyUS$2,000,004	Tellus BioVentures, LLC	Company	166,667	US$12.00

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of DNTH?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	65,028	0.183%
Private Companies	1,090,283	3.07%
Hedge Funds	7,377,608	20.8%
VC/PE Firms	8,592,420	24.2%
Institutions	18,413,001	51.8%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 99.7%.

Top Shareholders

Top 25 shareholders own 112.9% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
14.9%	FMR LLC	4,403,148	US$100.8m	0.02%	0.01%
10.2%	Bain Capital Life Sciences Investors, LLC	3,013,423	US$69.0m	0%	7.31%
9.9%	Avidity Partners Management, L.P.	2,930,250	US$67.1m	0.45%	3.84%
9.12%	Fairmount Funds Management LLC	2,700,691	US$61.8m	-2.25%	5.09%
7.88%	RA Capital Management, L.P.	2,333,000	US$53.4m	0%	0.66%
5.9%	Octagon Capital Advisors LP	1,746,667	US$40.0m	0%	6.46%
5.89%	VR Adviser, LLC	1,744,373	US$39.9m	-16.7%	2.05%
5.56%	BlackRock, Inc.	1,644,819	US$37.7m	2.57%	no data
5.07%	TCG Crossover Management, LLC	1,501,624	US$34.4m	0%	3.1%
4.85%	Tellus BioVentures, LLC	1,436,745	US$32.9m	0%	no data
4.38%	The Vanguard Group, Inc.	1,294,969	US$29.7m	3.99%	no data
4.16%	5AM Venture Management, LLC	1,231,619	US$28.2m	-0.11%	6.16%
3.68%	Viridian, LLC	1,090,283	US$25.0m	0%	no data
3.46%	AllianceBernstein L.P.	1,023,143	US$23.4m	3,990%	0.01%
3.21%	Janus Henderson Group plc	949,334	US$21.7m	40.5%	0.01%
2.77%	State Street Global Advisors, Inc.	821,131	US$18.8m	101%	no data
2.25%	RTW Investments, LP	666,667	US$15.3m	0%	0.22%
1.72%	Point72 Asset Management, L.P.	508,990	US$11.7m	106%	0.03%
1.67%	Braidwell LP	493,687	US$11.3m	34.6%	0.51%
1.64%	Geode Capital Management, LLC	485,121	US$11.1m	-2.77%	no data
1.33%	Vestal Point Capital, LP	395,000	US$9.0m	-34.2%	0.73%
0.93%	Great Point Partners, LLC	275,000	US$6.3m	-63.7%	2.43%
0.89%	Tang Capital Management, LLC	264,692	US$6.1m	0%	0.45%
0.85%	Woodline Partners LP	250,504	US$5.7m	0.07%	0.05%
0.71%	GV Management Company, LLC	208,697	US$4.8m	0%	0.32%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/26 23:10
End of Day Share Price	2024/12/26 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Dianthus Therapeutics, Inc. is covered by 11 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Joel Beatty	Baird
Pete Stavropoulos	Cantor Fitzgerald & Co.
Gavin Clark-Gartner	Evercore ISI